carbon monoxide has been researched along with Esophageal Neoplasms in 5 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Computed tomography-measured sarcopenia, and pulmonary function (forced expiratory volume in first second/forced vital capacity/diffusion capacity for carbon monoxide) were compared pretherapy and posttherapy." | 5.51 | CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison. ( Cools-Lartigue, J; Cunningham, M; Davern, M; Donlon, NE; Donohoe, CL; Ferri, L; Kamilli, A; King, S; Lowery, M; Moran, B; Mueller, C; Ravi, N; Reynolds, JV; Sheppard, A, 2022) |
| "As the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased." | 1.91 | Feasibility analysis of combined surgery for esophageal cancer. ( Huang, C; Li, K; Li, X; Liu, X; Sun, S; Wang, Z; Zhang, G, 2023) |
| "Thirty patients with cancer of the esophagus were treated with multimodality therapy." | 1.27 | Pulmonary complications of multimodality therapy for esophageal carcinoma. ( Chalaoui, J; Duprat, G; Duranceau, A; Robidoux, A; Sylvestre, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donlon, NE | 1 |
| Moran, B | 1 |
| Kamilli, A | 1 |
| Davern, M | 1 |
| Sheppard, A | 1 |
| King, S | 2 |
| Donohoe, CL | 1 |
| Lowery, M | 1 |
| Cunningham, M | 1 |
| Ravi, N | 2 |
| Mueller, C | 1 |
| Cools-Lartigue, J | 1 |
| Ferri, L | 1 |
| Reynolds, JV | 2 |
| Wang, Z | 1 |
| Sun, S | 1 |
| Li, K | 1 |
| Huang, C | 1 |
| Liu, X | 1 |
| Zhang, G | 1 |
| Li, X | 1 |
| Yoshida, N | 1 |
| Baba, Y | 1 |
| Kuroda, D | 1 |
| Miyamoto, Y | 1 |
| Iwatsuki, M | 1 |
| Hiyoshi, Y | 1 |
| Ishimoto, T | 1 |
| Sawayama, H | 1 |
| Imamura, Y | 1 |
| Watanabe, M | 1 |
| Baba, H | 1 |
| Elliott, JA | 1 |
| O'Byrne, L | 1 |
| Foley, G | 1 |
| Murphy, CF | 1 |
| Doyle, SL | 1 |
| Guinan, EM | 1 |
| Duprat, G | 1 |
| Chalaoui, J | 1 |
| Sylvestre, J | 1 |
| Robidoux, A | 1 |
| Duranceau, A | 1 |
2 trials available for carbon monoxide and Esophageal Neoplasms
| Article | Year |
|---|---|
CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Esophageal Neoplasm | 2022 |
Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carboplatin; Chemoradiotherapy, Adj | 2019 |
3 other studies available for carbon monoxide and Esophageal Neoplasms
| Article | Year |
|---|---|
Feasibility analysis of combined surgery for esophageal cancer.
Topics: Carbon Monoxide; Esophageal Neoplasms; Esophagectomy; Feasibility Studies; Female; Humans; Male; Mid | 2023 |
Clinical utility of exhaled carbon monoxide in assessing preoperative smoking status and risks of postoperative morbidity after esophagectomy.
Topics: Aged; Aged, 80 and over; Breath Tests; Carbon Monoxide; Esophageal Neoplasms; Esophagectomy; Exhalat | 2018 |
Pulmonary complications of multimodality therapy for esophageal carcinoma.
Topics: Bleomycin; Breath Tests; Carbon Monoxide; Carcinoma, Squamous Cell; Combined Modality Therapy; Esoph | 1987 |